Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Distribution Agreement Formed Between Chr. Hansen, Urex, BioGaia - Nutraceuticals World
Market Updates

Distribution Agreement Formed Between Chr. Hansen, Urex, BioGaia

Distribution Agreement Formed Between Chr. Hansen, Urex, BioGaia
Chr. Hansen A/S, Hørsholm, Denmark, Urex Biotech Inc., London, Ontario, and BioGaia, Stockholm, Sweden, have entered into agreements that will allow for the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targeting women. The product is an oral probiotic that restores and maintains a healthy vaginal flora in order to diminish the risk of acquiring urogenital infections. The product will be distributed through combined distribution networks of Chr. Hansen and BioGaia.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters